XOMA - XOMA expands portfolio with DSUVIA acquisition; shares tick lower
2024-01-18 12:11:26 ET
More on XOMA
- XOMA Preferreds: I Upped My Rating On One Preferred Stock To A Buy
- Xoma to pay $1M to LadRx as rare disease therapy undergoes FDA review
- Xoma appoints Owen Hughes as CEO, Jack Wyszomierski as chairman
- Seeking Alpha’s Quant Rating on XOMA
- Historical earnings data for XOMA
For further details see:
XOMA expands portfolio with DSUVIA acquisition; shares tick lower